Automated Versus Handheld Breast Ultrasound for Evaluating Axillary Lymph Nodes in Patients With Breast Cancer-Reference-Cited by-同舟云学术

Automated Versus Handheld Breast Ultrasound for Evaluating Axillary Lymph Nodes in Patients With Breast Cancer

Published:2024 Issue:2 Volume:25 Page:146
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Kim Sun Mi¹^ORCID,Jang Mijung¹^ORCID,Yun Bo La¹^ORCID,Shin Sung Ui²^ORCID,Rim Jiwon³^ORCID,Kang Eunyoung⁴^ORCID,Kim Eun-Kyu⁵^ORCID,Shin Hee-Chul⁵^ORCID,Park So Yeon⁶^ORCID,Kim Bohyoung⁷^ORCID

Affiliation:

1. Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

2. Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

3. Department of Radiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.

4. Department of Surgery, Daerim St. Mary’s Hospital, Seoul, Republic of Korea.

5. Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

6. Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

7. Division of Biomedical Engineering, Hankuk University of Foreign Studies, Yongin, Republic of Korea.

Funder

Seoul National University Bundang Hospital

Publisher

XMLink

Link

https://kjronline.org/pdf/10.3348/kjr.2023.0100

Reference30 articles.

1. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

2. Level I and II Axillary Dissection in the Treatment of Early-Stage Breast Cancer

3. A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer

4. A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer

5. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial